Mackenzie Financial
PRCT icon

Mackenzie Financial’s Procept Biorobotics PRCT Stock Holding History

Mackenzie Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,720,738
Closed -$43M – 1661
2026
Q1 		$43M Buy
1,720,738
+147,333
+9% +$4.15M 0.05% 282
2025
Q4 		$49.5M Buy
1,573,405
+118,971
+8% +$3.95M 0.06% 254
2025
Q3 		$51.9M Buy
1,454,434
+745,778
+105% +$34.1M 0.06% 239
2025
Q2 		$40.8M Buy
+708,656
New +$40.1M 0.05% 256
2025
Q1 		– Sell
-2,829
Closed -$228K – 1775
2024
Q4 		$228K Buy
2,829
+125
+5% +$10.7K ﹤0.01% 1510
2024
Q3 		$217K Buy
+2,704
New +$192K ﹤0.01% 1349

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mackenzie Financial's PRCT Position: Q2 2026 in Review

Mackenzie Financial sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 1,720,738 shares — an estimated $43M sold.

Mackenzie Financial first reported a position in PRCT in Q3 2024 and held it in 6 quarters. The position peaked at $51.9M in Q3 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Mackenzie Financial reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Mackenzie Financial sold 1,720,738 Procept Biorobotics shares in Q2 2026, an estimated $43M.
  • Mackenzie Financial first reported a position in Procept Biorobotics in Q3 2024 and held it in 6 quarters.
  • Mackenzie Financial's Procept Biorobotics position peaked at $51.9M in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.